Genmab Report issue

Contributed to NME For profit Phase 2 Phase 3 Phase 4
Founded: Copenhagen Denmark (1999)

Organization Overview

First Clinical Trial
2003
NCT00093041
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Genmab | Genmab A/S, Bredgade 34, DK-1260 Copenhagen K, Denmark | Genmab employee